ArticleCureus2024
Oligo-Metastatic Ductal Breast Carcinoma Presenting as a Subcutaneous Nape Nodule: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer (BC) in females is the most diagnosed cancer and the leading cause of cancer death in women worldwide, followed by lung, colorectal, and cervical cancers. For oligo-metastatic (OM) cancers, the best definition is a maximum of five metastatic foci, not necessarily located in the same organ or anatomic region, all potentially treatable by ablative local treatment: either surgical resection or radiation when accessible. Oligo-metastatic breast cancer (OM-BC) is currently arising as an emerging entity with more focused research needed to upgrade the guidelines for best management. Given the heterogeneous nature of BC metastasis, evolving molecular mechanisms have been shown to play a lead way for possible future-guided preventive therapy. Soft tissue metastases are particularly very rare and usually seen arising in subcutaneous fat, fascia, or muscle fibers. They can be confused with a primary soft tissue sarcoma and hence it is important to obtain an accurate differential diagnosis. We hereby present a case of OM-BC presenting as a metastatic soft tissue nodule in the nape in a 73-year-old Kuwaiti lady diagnosed with left breast cancer in 2016 (ductal type) with otherwise free metastatic workup in our practice at Kuwait Cancer Control Center (KCCC).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.